SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO 
Trump, Xi Begin High-Stakes China Summit Focused on Trade, Taiwan and Global Tensions 
EQT Launches $3.76 Billion Take-Private Deal for Kakaku.com as Shares Surge 
Dollar Surges as Inflation Data Fuels Fed Rate Hike Expectations 
Cisco Restructures for AI Growth After Record Q3 Revenue 
Gold Prices Steady Ahead of Trump-Xi Meeting as Inflation and Oil Concerns Persist 
New Zealand Budget 2026 Focuses on Fiscal Discipline and Infrastructure Investment 
Dollar Gains as Fed Rate Hike Bets Rise Ahead of Trump-Xi Summit 
Honda Annual Loss Deepens as U.S. Tariffs and EV Costs Weigh on Earnings 
Havana Protests Erupt as Cuba Faces Severe Blackouts and Fuel Crisis 
Asian Stocks Edge Higher as Tech Shares Rise Ahead of Trump-Xi Beijing Summit 
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan 
Trump and Xi Temple of Heaven Visit Highlights Trade and Diplomacy Goals 
Asian Currencies Hold Steady as Strong U.S. Inflation Data Boosts Dollar 
Coles “Down Down” Ruling Sparks Fresh Scrutiny of Australian Supermarket Pricing 
Japan’s Top Banks to Gain Access to Anthropic’s Claude Mythos AI Model 
Kakao Healthcare Corp. and Dexcom Inc. have embarked on a groundbreaking partnership to provide continuous glucose monitoring (CGM) for diabetes patients, starting in South Korea with plans for global expansion.
Kakao Healthcare and Dexcom are looking to offer sugar management services in South Korea first and then expand globally. Their target is to provide the CGM glucose management service in more countries next year.
As per The Korea Economic Daily, with the tie-up, Kakao Corporation's healthcare arm just took another step forward in bringing its business into key markets outside Korea. This strategic partnership with Dexcom will help it provide digital blood sugar management services using Kakao Healthcare's software and artificial intelligence technology.
"We will achieve global expansion of K-digital healthcare while making efforts to promote public health and create social values in South Korea," Hwang Hee, Kakao Healthcare's chief executive officer, said in a statement.
The Korea Times further quoted the CEO as saying, "The agreement with Dexcom will enable us to launch our innovative CGM-based blood glucose management service domestically and expand globally. As a member of Kakao, we will strive to improve public health and create social value in Korea and achieve global expansion of Korea's digital healthcare industry."
Meanwhile, it was in April this year when Kakao Healthcare and Dexcom first met up to sign the memorandum of understanding in Boston. They expanded their contract and agreed to pursue a joint global business this time and will promote a personalized digital blood glucose management service together.
Kakao Healthcare and Dexcom are launching the new CGM service in the fourth quarter of this year in Korea, then gradually adding more countries. "By combining Kakao Healthcare's software and AI technology capabilities with Dexcom's continuous glucose monitoring (CGM) hardware capabilities, the two companies will provide innovative blood glucose management solutions," the Korean firm said.
Photo by: Kakao Newsroom
